Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Dechra Pharma 6-month Underlying EPS Up - Quick Facts

Dechra Pharmaceuticals Plc's (DPH.L) six-month pre-tax profit decreased to 8.9 million pounds from 9.0 million pounds in the prior-year period. On a per share basis, half-yearly earnings improved to 10.06 pence from 10.05 pence a year ago.

Underlying pre-tax profit was 14.3 million pounds compared with 13.9 million pounds achieved in 2010. At constant currency and excluding foreign currency gains and losses, underlying pre-tax profit was £15.1 million, up 11.3% versus 2010. Underlying earnings per share were 15.82 pence, higher than last year's 15.51 pence.

Revenue for the six months ended December 31, 2011 totaled 209.5 million pounds, up 9.0% from 192.2 million pounds in the previous year.

The board also declared an interim dividend of 4.1 pence per share, an increase of 10.8%, payable on 10 April 2012 to Shareholders on the Register of Members at close of business on 9 March 2012. The ordinary shares would become ex dividend on 7 March 2012.

Click here to receive FREE breaking news email alerts for Dechra Pharm PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Colorado based doctor Dilip Joseph, who was kidnapped by the Taliban discusses his ordeal in detail in a book published by Amazon on Tuesday. Extending the rebound seen over the course of the previous session, stocks moved sharply higher during trading on Friday. The gains on the day partly offset the recent sell-off on Wall Street, although the major averages remain well off their mid-September highs. While the Ebola outbreak in the U.S. has thus far been limited to just three people, the results of a new CBS News poll suggest that news of the disease has contributed to a sharp drop in public confidence in the Centers for Disease Control and Prevention.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.